Skip to main content
RSC Advances logoLink to RSC Advances
. 2026 Feb 16;16(9):7967–7973. doi: 10.1039/d6ra00218h

Molecular iodine catalyzed C3-quaternization via oxidative dearomatization of indoles: direct access to 3,3-di(indolyl)indolin-2-ones

Neetika Singh a, Hari Prasad Kokatla a,, Nagaraju Naddi a, Madhu Inapanuri a
PMCID: PMC12908625  PMID: 41704951

Abstract

An efficient and sustainable method for the synthesis of 3,3-di(indolyl)indolin-2-one derivatives has been developed via iodine-catalyzed oxidative dearomatization, where indole alone directly participates in the reaction. Utilising iodine as a green oxidant and DMSO as the optimal solvent, the reaction proceeds under mild conditions, eliminating the need for pre-functionalized indoles and minimising waste, aligning with green chemistry principles. The optimized protocol demonstrates broad substrate scope, high yields, and excellent selectivity, tolerating various functional groups.


Molecular iodine promotes the direct synthesis of 3,3-diindolyl-indoline-2-one from indole via oxidative dearomatization. The reaction proceeds through in situ isatin formation, offering a green, metal-free pathway to C3-quaternized indoles.graphic file with name d6ra00218h-ga.jpg

Introduction

The oxindole framework is a privileged heterocyclic scaffold frequently encountered in natural products, pharmaceuticals, and bioactive molecules, and has received considerable attention in synthetic and medicinal chemistry.1,2 Within this class, 3,3-disubstituted oxindoles are particularly important owing to their structural rigidity, extended π-conjugation, and nitrogen-rich environment.3,4 These attributes align them with pharmacologically relevant scaffolds and underpin their diverse biological activities, including spermicidal,5 antimicrobial,6 enzyme inhibition,7–9 and anticancer properties (Fig. 1).10–12

Fig. 1. Representative examples of pharmacologically active 3,3-bis(indol-3-yl)indolinones.

Fig. 1

Among the known derivatives, 3,3-di(indolyl)indolin-2-ones represent a compelling subclass, wherein two indole moieties are anchored at the C3-position of an oxindole synthon. Indolin-2-one and indolin-3-one scaffolds have attracted considerable attention due to their presence in numerous bioactive natural products and pharmaceuticals.13,14 Within this framework, the synthesis of C2-quaternary indolin-3-ones has been widely studied, leading to diverse and efficient methodologies.15–19 In contrast, the chemistry of C3-quaternary indolin-2-ones has remained relatively limited, despite their potential significance. This gap underscores the opportunity for further methodological development to access these valuable structural motifs, which impart distinct steric and electronic features, making them highly valuable for medicinal chemistry applications.

Existing strategies toward 3,3-di(indolyl)indolin-2-ones require prefunctionalized indoles such as isatins,20 oxindole21 or 3-diazo oxindoles,22 as well as pseudomulticomponent23 strategies that demand specialised reagents. The most widely adopted strategies are the condensation of isatins with indoles in the presence of catalysts such as acidic promoters (e.g., silica sulfuric acid,24 Amberlyst-15,25 TsOH,26 cellulose sulfuric acid,27 HFIP28), metal-based catalysts (e.g., FeCl3,29 CAN,30 nanocrystalline MgAl2O4,31 silica-supported In(acac)3),32 and palladium nanoparticles.33 However, Liu et al. developed a method for the synthesis of 3,3-biindoline-2-ones by silver/TEMPO catalytic system, and they observed trace amounts of the 3,3-di(indolyl)indolin-2-ones.34 Although these approaches can deliver the desired framework, they often suffer from poor atom economy, restricted substrate scope, and operational complexity.

In recent years, oxidative strategies have attracted increasing attention as viable alternatives for accessing oxindole architectures. In this context, iodine-based systems, particularly the I2/DMSO combination, have emerged as powerful platforms for indole functionalization through oxidative dearomatization pathways. The I2/DMSO system has been successfully employed for the oxygenation of indoles to afford isatins as well as for iodine-catalyzed oxidative coupling of indolin-2-ones with indoles to generate 3,3-disubstituted oxindole frameworks.35–37 While these reports highlight the efficiency of I2/DMSO systems, they predominantly rely on pre-oxidized intermediates or specific substrate classes, leaving substantial scope for the development of complementary strategies that enable direct C3-quaternization from simple indoles under milder and more sustainable conditions.

In this context, molecular iodine stands out as an attractive reagent, being mild, inexpensive, and environmentally benign, with wide utility in oxidative transformations.38 Our group has previously demonstrated the usefulness of iodine catalysis in C–H functionalization, exemplified by the iodine-catalysed C2–H formamidation of quinoline N-oxides using isocyanides.39 Motivated by these results, we envisaged extending iodine-mediated oxidative strategies to achieve direct dearomatization for the construction of C3-quaternary indolin-2-ones (Scheme 1).

Scheme 1. Strategies for the formation of C3-quaternary indolin-2-ones.

Scheme 1

Herein, we describe an operationally simple, iodine-mediated oxidative dearomatization methodology that provides direct, metal-free, and atom-economical access to 3,3-di(indolyl)indolin-2-ones directly from indoles. This strategy eliminates the need for preactivated substrates, proceeds under mild conditions, and delivers products with high selectivity, establishing a sustainable platform for the synthesis of biologically relevant scaffolds.

Results and discussion

In our preliminary investigations, we sought to establish an efficient protocol for the synthesis of 3,3-di(indolyl)indolin-2-one 2a using indole 1a (1.0 mmol) and iodine as a catalyst. The reaction was initially examined in a variety of common organic solvents employing I2 (10 mol%) under thermal conditions. However, non-polar and moderately polar solvents such as CH2Cl2, CHCl3, THF, CH3CN, toluene, EtOH, DMF, and H2O failed to promote the desired transformation, and no reaction was observed even after prolonged heating (Table 1, entries 1–8). Gratifyingly, a dramatic solvent effect was observed when the reaction was conducted in DMSO. Under these conditions, the desired product 2a was obtained in an excellent 84% yield within 5 h at 100 °C (Table 1, entry 9). The superior performance of DMSO can be attributed to its high polarity and ability to stabilize iodine-derived reactive intermediates, thereby facilitating efficient C–C bond formation. The structure of 2a was unambiguously confirmed by 1H NMR, 13C NMR, DEPT-135, and HRMS analyses (see SI).

Table 1. Optimization studiesa.

graphic file with name d6ra00218h-u1.jpg
Entry Catalyst Solvent Temp. (°C) Time (h) Yield (%)b
1 I2 CH2Cl2 30 12 n.r.c
2 I2 CHCl3 50 12 n.r.c
3 I2 THF 100 10 n.r.c
4 I2 CH3CN 70 8 n.r.c
5 I2 Toluene 100 12 n.r.c
6 I2 EtOH 60 24 n.r.c
7 I2 DMF 100 12 n.r.c
8 I2 H2O 90 24 n.r.c
9 I2 DMSO 100 5 84
10 I2 DMSO 100 7 59d
11 I2 DMSO 100 7 77e
12 I2 DMSO 100 7 53f
13 I2 DMSO 100 7 53g
14 I2 DMSO 100 8 33h
15 I2 DMSO 100 8 32i
16 NIS DMSO 100 8 40
17 KI DMSO 100 24 n.r.c
a

Reaction conditions: indole (1.0 mmol), catalyst (10 mol%), solvent (2 mL), stirred at the specified temperature under open atmosphere.

b

Isolated yields.

c

n.r. = no reaction.

d

2 mol%.

e

5 mol%.

f

15 mol%.

g

20 mol%.

h

25 mol%.

i

30 mol%.

Subsequently, the influence of iodine loading was examined in DMSO. Reducing the catalyst loading to 2 and 5 mol% resulted in diminished yields of 59% and 77%, respectively, after 7 h, indicating incomplete conversion under these conditions (Table 1, entries 10 and 11). Conversely, increasing the iodine loading beyond the optimal 10 mol% proved detrimental. Higher catalyst loadings (15–30 mol%) led to a significant decrease in product yield (32–53%; Table 1, entries 12–15), presumably due to competitive side reactions or overoxidation processes induced by excess iodine.

Other iodine sources were also evaluated. N-iodosuccinimide (NIS) afforded only a moderate 40% yield under otherwise identical conditions (Table 1, entry 16), while potassium iodide (KI) was completely ineffective, showing no reaction even after 24 h (Table 1, entry 17).

Overall, these optimization studies highlight the crucial interplay of solvent polarity, iodine stoichiometry, and temperature in maximizing the efficiency of this iodine-mediated indole coupling reaction. Once the optimal conditions were established, we extended our study to explore the scope of the reaction with a variety of indole derivatives (Scheme 2). Under the optimized reaction conditions, 1H-indole 1a underwent a smooth transformation to afford the corresponding product 2a in excellent yield (Scheme 2), demonstrating the baseline reactivity of the parent scaffold. Electron-donating groups on the benzene ring, such as 5-methoxy-1H-indole 1b and 5-(benzyloxy)-1H-indole 1c substituents, were well tolerated, affording the desired products 2b–2c in good yields (Scheme 2). These results highlight the method's compatibility with electron-rich aromatic systems.

Scheme 2. Substrate scopea,b. aReaction conditions: All the reactions were conducted on a 1.0 mmol scale of 1a–t (1.0 mmol) and iodine (10 mol%) in DMSO solvent (2 mL) at 100 °C. bIsolated yields.

Scheme 2

Similarly, halogens such as fluoro, chloro, and bromo at various positions on the benzene ring 1d–1g also underwent efficient transformation to deliver the corresponding products 2d–2g in moderate-to-good yields 74–84% (Scheme 2). The successful incorporation of halogenated indoles underscores the robustness of the protocol and its potential for further synthetic elaboration.

However, indoles bearing electron-withdrawing substituents, such as ethyl 1H-indole-5-carboxylate 1h and 1H-indole-5-carbonitrile 1i, exhibited reduced reactivity, affording the corresponding products 2h and 2i (Scheme 2) in only 56% and 52% yields, respectively, likely due to decreased electron density on the aromatic ring, adversely affecting the reaction efficiency. Notably, nitro-substituted indoles 1u predominantly yielded the corresponding NO2-isatin 4 (Scheme 3) instead of the 5,5′,5″-trinitro-[3,3′:3′,3″-terindolin]-2′-one and the NMR data confirming the formation of the NO2-substituted isatin 4 are provided in the SI. This behaviour indicates that although substrate consumption occurs, the intrinsic reactivity of electron-deficient indoles favours overoxidation rather than controlled C3-quaternization. Furthermore, a broad range of N-alkylated indoles bearing various alkyl chains, including methyl, ethyl, propyl, butyl, pentyl, hexyl, tetradecane, octadecane, and cyclopentyl 1j–1r underwent smooth conversion, affording their respective products 2j–2r (Scheme 2) in good-to-excellent yields. Notably, N-alkylated methoxy indole 1s and N-alkylated bromo-substituted indole 1t were also compatible under the reaction conditions, affording 2s and 2t (Scheme 2) in similarly high yields, highlighting the method's tolerance to both steric and electronic diversity at the nitrogen atom.

Scheme 3. Conversion of 5-nitroindole to 5-nitroindoline-2,3-dione.

Scheme 3

It is noteworthy that substrates bearing strong electron-withdrawing substituents, such as 5-nitroindole 1u and N-Boc indole 1v, failed to undergo the transformation, presumably because the electron-withdrawing groups significantly reduce the nucleophilicity of the indole core. Likewise, N-allyl indole 1w, N-propargyl indole 1x and C-2 substituted indoles 1y–1z also proved unreactive, which may be attributed to potential interactions of the allyl or propargyl functionalities with iodine and blocking of substitutions on C-2 position (Scheme 2).

All synthesized compounds 2a–2t (Scheme 2) were characterized using 1H NMR, 13C NMR, and mass spectrometry. The molecular structure of compound 2j was unambiguously confirmed through single-crystal X-ray diffraction (XRD) analysis (Fig. 2). Detailed crystallographic data and refinement parameters are provided in the SI (Table S1). This optimized protocol demonstrates excellent efficiency and broad substrate scope, allowing the synthesis of structurally diverse 3,3-di(indolyl)indolin-2-ones with high regioselectivity and yields.

Fig. 2. ORTEP representations of X-ray crystal structures of 1,1′,1″-trimethyl-1H,1″H-[3,3′:3′,3″-terindol]-2′(1′H)-one 2j. The thermal ellipsoids are drawn at a 50% probability level.

Fig. 2

The method is tolerant to various functional groups and provides a platform for further chemical modifications, showcasing its potential utility in synthetic and medicinal chemistry.

To elucidate the reaction mechanism, the control experiments were conducted to investigate the role of iodine and reactive intermediates, and the results are summarized in Scheme 4. Initially, the reaction of indole 1a in DMSO at 100 °C, in the absence of iodine (10 mol%), was performed, which resulted in no formation of the desired product 2a, highlighting the essential role of iodine in the transformation (Scheme 4a).

Scheme 4. Control experiments.

Scheme 4

During the optimization of reaction conditions (Table 1), a yellow spot was observed on TLC and disappeared during the course of the reaction; this intermediate was isolated by quenching the reaction mixture at an early stage and was identified as isatin by comparison with an authentic sample. The formation of isatin I was further confirmed by NMR analysis, and the corresponding data are provided in the SI. These observations indicate that isatin is generated in situ through the reaction of indole 1a with iodine (Scheme 4b). Additionally, the reaction of indole 1a with HI alone did not afford the desired product, suggesting that HI is not competent to mediate the transformation (Scheme 4c).

To further validate the involvement of isatin as a key intermediate, preformed isatin was treated with indole 1a under the standard reaction conditions, which resulted in the formation of the desired 3,3-di(indolyl)indoline-2-one 2a in 70% yield, thereby confirming the feasibility of isatin in the proposed reaction pathway (Scheme 4d). Furthermore, when the reaction was carried out in the presence of the radical scavenger TEMPO, the formation of product 2a was completely suppressed, and no product was detected (0% yield), indicating the possible involvement of a radical pathway in the reaction (Scheme 4e).

Based on the control experiments and literature reports,35,36 a plausible mechanism is outlined in Scheme 5. Initially, indole undergoes in situ oxidation by molecular iodine to form isatin I, which subsequently undergoes nucleophilic attack with indole at the C-3 position of isatin to generate intermediate III. Upon dehydration of intermediate III, a Michael acceptor 2-oxoindolin-3-ylidene-3H-indol-1-ium IV is formed. Subsequently, indole π electrons attack on intermediate IVvia Michael addition to form intermediate V, which then undergoes aromatization to produce the desired product 2a (Scheme 5).

Scheme 5. Plausible reaction mechanism.

Scheme 5

Conclusions

In this study, we have developed an efficient, sustainable, and straightforward strategy for iodine-catalysed oxidative dearomatization to synthesise 3,3-di(indolyl)indolin-2-one derivatives directly from indoles. By using molecular iodine as a green oxidant in DMSO solvent, our method avoids the need for pre-functionalized substrates, reduces the number of reaction steps, and aligns with the principles of green chemistry. The protocol demonstrated a broad substrate scope, wide functional group tolerance, and the use of a green oxidising agent. This methodology not only expands the synthetic toolbox for accessing 3,3-di(indolyl)indolin-2-one scaffolds but also provides a foundation for further functionalization and exploration of these biologically significant compounds.

Author contributions

N. Singh and H. P. Kokatla designed the work, and N. Singh performed all the synthesis and characterization studies. N. Nagaraju and I. Madhu prepared the starting materials. All authors contributed to discussions. The manuscript was written by N. Singh and H. P. Kokatla.

Conflicts of interest

“There are no conflicts to declare”.

Supplementary Material

RA-016-D6RA00218H-s001
RA-016-D6RA00218H-s002

Acknowledgments

The author H.P.K. is grateful to the Anusandhan National Research Foundation (file nos. SERB-SCP/2022/000273, SERB-EEQ/2022/000511) and to the DST-FIST grant (SR/FST/CSII/2018/65) awarded to the Department of Chemistry, NIT Warangal, for financial support of this work. Neetika Singh gratefully acknowledges the Department of Science & Technology, Government of India, for financial support vide reference no. DST/WISE-PhD/CS/2024/38 (G) under the ‘DST-WISE Fellowship for PhD’ programme to carry out the research work. Central Research Instrumentation Facility (CRIF), for NMR and HRMS analysis, and NIT Warangal for infrastructure are acknowledged.

Data availability

CCDC 2490627 contains the supplementary crystallographic data for this paper.40

The data supporting this article have been included as part of the supplementary information (SI). Experimental procedures, characterization data, and copies of the 1H, 13C{1H} and HRMS spectra of all compounds are included. Supplementary information is available. See DOI: https://doi.org/10.1039/d6ra00218h.

Notes and references

  1. Khetmalis Y. M. Shivani M. Murugesan S. Chandra Sekhar K. V. G. Biomed. Pharmacother. 2021;141:111842. doi: 10.1016/j.biopha.2021.111842. [DOI] [PubMed] [Google Scholar]
  2. Zhang M. Li Y. Wang Y. Shu J. Zhang T. Zhang D. Cai S. Shi T. Hu W. Green Synth. Catal. 2024;5:180–185. [Google Scholar]
  3. Suzuki H. Sekino K. Kondo S. Minamikawa R. Matsuda T. Org. Biomol. Chem. 2024;22:6282–6287. doi: 10.1039/d4ob00964a. [DOI] [PubMed] [Google Scholar]
  4. Nichinde C. B. Patil B. R. Chaudhari S. S. Mali B. P. Gonnade R. G. Kinage A. K. RSC Adv. 2023;13:13206–13212. doi: 10.1039/d3ra00510k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Paira P. Hazra A. Kumar S. Paira R. Sahu K. B. Naskar S. Saha P. Mondal S. Maity A. Banerjee S. Mondal N. B. Bioorg. Med. Chem. Lett. 2009;19:4786–4789. doi: 10.1016/j.bmcl.2009.06.049. [DOI] [PubMed] [Google Scholar]
  6. Karimi A. R. Dalirnasab Z. Yousefi G. H. Akbarizadeh A. R. Res. Chem. Intermed. 2015;41:10007–10016. [Google Scholar]
  7. Gupta J. Ahuja A. Gupta R. Anti-Cancer Agents Med. Chem. 2022;22:101–114. doi: 10.2174/1871520621666210119091826. [DOI] [PubMed] [Google Scholar]
  8. Wang G. Wang J. Xie Z. Chen M. Li L. Peng Y. Chen S. Li W. Deng B. Bioorg. Chem. 2017;72:228–233. doi: 10.1016/j.bioorg.2017.05.006. [DOI] [PubMed] [Google Scholar]
  9. Santoso M. Ong L. L. Aijijiyah N. P. Wati F. A. Azminah A. Annuur R. M. Fadlan A. Judeh Z. M. A. Heliyon. 2022;8:e09045. doi: 10.1016/j.heliyon.2022.e09045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Natarajan A. Fan Y. H. Chen H. Guo Y. Iyasere J. Harbinski F. Christ W. J. Aktas H. Halperin J. A. J. Med. Chem. 2004;47:1882–1885. doi: 10.1021/jm0499716. [DOI] [PubMed] [Google Scholar]
  11. Kaur S. Kaur J. Kaur K. Mahajan R. Jyotisina Kaur K. Curr. Indian Sci. 2024;2:e2210299X310595. [Google Scholar]
  12. Christodoulou M. S. Nicoletti F. Mangano K. Chiacchio M. A. Facchetti G. Rimoldi I. Beccalli E. M. Giofrè S. Bioorg. Med. Chem. Lett. 2020;30:126845. doi: 10.1016/j.bmcl.2019.126845. [DOI] [PubMed] [Google Scholar]
  13. Rasmussen H. B. MacLeod J. K. J. Nat. Prod. 1997;60:1152–1154. doi: 10.1021/np970006a. [DOI] [PubMed] [Google Scholar]
  14. Tayade Y. A. Patil D. R. Wagh Y. B. Jangle A. D. Dalal D. S. Tetrahedron Lett. 2015;56:666–673. doi: 10.1016/j.tetlet.2014.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gohain S. B. Basumatary M. Boruah P. K. Das M. R. Thakur A. J. Green Chem. 2022;24:5338. [Google Scholar]
  16. Guchhait S. K. Chaudhary V. Rana V. A. Priyadarshani G. Kandekar S. Kashyap M. Org. Lett. 2016;18:1534–1537. doi: 10.1021/acs.orglett.6b00244. [DOI] [PubMed] [Google Scholar]
  17. Xu H. Yamaguchi S. Mitsudome T. Mizugaki T. Eur. J. Org Chem. 2022;2022:e202200826. [Google Scholar]
  18. Banu S. Choudhari S. Patel G. Yadav P. P. Green Chem. 2021;23:3039–3047. [Google Scholar]
  19. Cheng L. T. Luo S. Q. Hong B. C. Chen C. L. Li W. S. Lee G. H. Org. Biomol. Chem. 2020;18:6247–6252. doi: 10.1039/d0ob01298j. [DOI] [PubMed] [Google Scholar]
  20. Rad-Moghadam K. Sharifi-Kiasaraie M. Taheri-Amlashi H. Tetrahedron. 2010;66:2316–2321. doi: 10.1016/j.tet.2010.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wu K. X. Xu Y. Z. Cheng L. Wu R. S. Liu P. Z. Xu D. Z. Green Chem. 2021;23:8448–8452. [Google Scholar]
  22. Kamboj P. Tyagi V. Green Chem. 2023;26:1990–1999. [Google Scholar]
  23. Brahmachari G. Banerjee B. ACS Sustain. Chem. Eng. 2014;2:2802–2812. [Google Scholar]
  24. Azizian J. Mohammadi A. A. Karimi N. Mohammadizadeh M. R. Karimi A. R. Catal. Commun. 2006;7:752–755. [Google Scholar]
  25. Sarrafi Y. Alimohammadi K. Sadatshahabi M. Norozipoor N. Monatsh. Chem. 2012;143:1519–1522. [Google Scholar]
  26. Suresh B. Brahmeshwary G. Swamy T. Gopi I. Ravinder V. Russ. J. Gen. Chem. 2016;86:1144–1150. [Google Scholar]
  27. Alinezhad H. Haghighi A. H. Salehian F. A. Chin. Chem. Lett. 2010;21:183–186. [Google Scholar]
  28. Yuan X. Wang S. Cheng J. Yu B. Liu H. M. Chin. Chem. Lett. 2020;31:2465–2468. [Google Scholar]
  29. Kamal A. Srikanth Y. V. V. Khan M. N. A. Shaik T. B. Ashraf M. Bioorg. Med. Chem. Lett. 2010;20:5229–5231. doi: 10.1016/j.bmcl.2010.06.152. [DOI] [PubMed] [Google Scholar]
  30. Wang S. Y. Ji S. J. Tetrahedron. 2006;62:1527–1535. [Google Scholar]
  31. Nikoofar K. Haghighi M. Khademi Z. Arab. J. Chem. 2019;12:3776–3784. [Google Scholar]
  32. Sharma R. K. Sharma C. J. Mol. Catal. A: Chem. 2010;332:53–58. [Google Scholar]
  33. Edayadulla N. Basavegowda N. Lee Y. R. J. Ind. Eng. Chem. 2015;21:1365–1372. [Google Scholar]
  34. Lin F. Chen Y. Wang B. Qin W. Liu L. RSC Adv. 2015;5:37018–37022. [Google Scholar]
  35. Rastogi G. K. Deka B. Deb M. L. Baruah P. K. Asian J. Org. Chem. 2022;11:2–8. [Google Scholar]
  36. Reddy B. V. S. Rajeswari N. Sarangapani M. Prashanthi Y. Ganji R. J. Addlagatta A. Bioorg. Med. Chem. Lett. 2012;22:2460–2463. doi: 10.1016/j.bmcl.2012.02.011. [DOI] [PubMed] [Google Scholar]
  37. Li R.-P. Wang Z.-L. Zhang Y.-H. Tan Z.-Y. Xu D.-Z. ChemistrySelect. 2022;7:202200558. [Google Scholar]
  38. Togo H. Iida S. Synlett. 2006;14:2159–2175. [Google Scholar]
  39. Anugu N. Thunga S. Golla S. Kokatla H. P. Adv. Synth. Catal. 2022;364:149–157. [Google Scholar]
  40. CCDC 2490627: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2plptt [DOI]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. CCDC 2490627: Experimental Crystal Structure Determination, 2026, 10.5517/ccdc.csd.cc2plptt [DOI]

Supplementary Materials

RA-016-D6RA00218H-s001
RA-016-D6RA00218H-s002

Data Availability Statement

CCDC 2490627 contains the supplementary crystallographic data for this paper.40

The data supporting this article have been included as part of the supplementary information (SI). Experimental procedures, characterization data, and copies of the 1H, 13C{1H} and HRMS spectra of all compounds are included. Supplementary information is available. See DOI: https://doi.org/10.1039/d6ra00218h.


Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES